Pay in 4 interest-free payments of $6.01 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
In a clinical trial involving individuals with established cardiovascular disease, retatrutide reduced the risk of major adverse cardiovascular events, such as heart attacks, strokes, and cardiovascular death
When you work with Koshland Pharm and your doctor, you will have the ability to adjust the dosage amount taken per week based on your bodys response
You are interested in medical weight management but the weekly injection has kept you from starting You prefer a daily tablet over a weekly shot You have a BMI of 27 or higher with a weight-related health concern, or a BMI of 30 or higher You want a clinician-led plan with eligibility review, labs, and monitoring rather than a self-directed approach You want a US-compounded option and care about where your medication comes from Your PepScribe clinician makes the final call on eligibility based on your health history and goals
In some cases, it may be administered as per the suggestion of doctor
